Gross Margin: A company's total sales revenue minus its cost of goods sold, divided by the total sales revenue, expressed as a percentage. Calculated as: Gross Income / Total Revenues
Collegium Pharmaceutical, Inc. (COLL) had Gross Margin of 61.70% for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$209.36M |
|
$31.51M |
|
$80.19M |
|
$129.17M |
|
$147.27M |
|
$62.09M |
|
$-18.65M |
|
$43.44M |
|
$43.44M |
|
$31.51M |
|
$31.51M |
|
$31.51M |
|
$31.51M |
|
$62.09M |
|
$118.36M |
|
31.57M |
|
39.44M |
|
$1.00 |
|
$0.84 |
|
| Balance Sheet Financials | |
$613.87M |
|
$12.25M |
|
$993.46M |
|
$1.61B |
|
$452.93M |
|
$743.53M |
|
$879.59M |
|
$1.33B |
|
$274.81M |
|
$-596.10M |
|
$274.81M |
|
31.60M |
|
| Cash Flow Statement Financials | |
$206.28M |
|
$-43.46M |
|
$-88.42M |
|
$96.61M |
|
$171.00M |
|
$74.39M |
|
$32.15M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.36 |
|
-- |
|
-- |
|
0.73 |
|
2.94 |
|
|
Gross Margin |
61.70% |
29.66% |
|
29.66% |
|
-- |
|
20.75% |
|
15.05% |
|
$205.22M |
|
-- |
|
-- |
|
-- |
|
0.13 |
|
2.11 |
|
0.89 |
|
100.57 |
|
11.47% |
|
-5.29% |
|
1.96% |
|
3.09% |
|
$8.70 |
|
$5.20 |
|
$5.23 |
|